EGFR and non-small cell lung carcinoma: Mutations in genes in the mTOR pathway, such as KRAS, epidermal growth factor receptor (EGFR), LKB1, PTEN, PIK3CA, AKT1, EGFR, PIK3CA, and PTEN, have some relationship with the development of NSCLC (29).